investorscraft@gmail.com

Stock Analysis & ValuationeXoZymes, Inc. (EXOZ)

Previous Close
$9.75
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

750 Royal Oaks Drive
Monrovia, NV 91016
United States
Phone: 626 415 1488
Industry: Biotechnology
Sector: Healthcare
CEO: Michael Heltzen
Full Time Employees: 31

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

HomeMenuAccount